IgG4 Sclerosing Lung Disease



IgG4 Sclerosing Lung Disease











IgG4 sclerosing lung disease shows a nodular, well-circumscribed area of lung parenchyma with prominent stromal sclerosis and reactive lymphoid follicles in the periphery.






Higher magnification from an area of stromal sclerosis in IgG4 sclerosing disease of the lung shows dense infiltrate composed of plasma cells admixed with the sclerotic stroma.


TERMINOLOGY


Definitions



  • Systemic disease of unknown etiology characterized by elevated production of IgG4(+) plasma cells and tissue stromal sclerosis


ETIOLOGY/PATHOGENESIS


Pathogenesis



  • Unknown, but an autoimmune mechanism or hypersensitivity reaction has been postulated


  • Circulating autoantibodies are present in many patients


  • May be associated with other autoimmune disorders, e.g., Sjögren syndrome


CLINICAL ISSUES


Epidemiology



  • Age



    • Middle-aged and elderly patients


  • Gender



    • Male predominance


Presentation



  • Asymptomatic incidental finding in chest x-ray


  • Cough


  • Hemoptysis


  • Dyspnea


  • Pleural effusion


Natural History



  • Slowly progressive disease with involvement of multiple sites over a period of years with elevation of serum titers of IgG4


  • Most commonly involved sites include pancreas, hepatobiliary tract, salivary gland, orbit, and lymph nodes


  • Prototype of disease is so-called autoimmune pancreatitis


  • May involve almost any other organ site in body


  • Benign clinical course with good response to steroids


  • Some cases may evolve to malignant lymphoma or may be associated with development of carcinoma


Prognosis



  • Excellent response to steroid therapy


MICROSCOPIC PATHOLOGY


Histologic Features

Jul 9, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on IgG4 Sclerosing Lung Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access